Company / Financials
InspireMD, Inc. Financials
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$7.0M
FY2025 · +13.0% YoY
Net Income
-$32.0M
FY2025 · -60.7% YoY
Profit Margin
-456.6%
FY2025 · net income / revenue
ROE
-88.7%
FY2025 · return on equity
Total Assets
$69.4M
FY2025
Total Debt
-
FY2025
Equity
$36.1M
FY2025
ROA
-46.1%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$7.0M+13.0% YoYNet Income HistoryProfit after all expenses and taxes-$32.0M-60.7% YoYGross Profit HistoryRevenue minus cost of goods sold$1.5M-16.7% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$5.5M+25.1% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$33.5M-58.5% YoYSG&A Expense HistorySelling, general, and administrative expenses$15.3M+37.8% YoYR&D Expense HistoryResearch and development spending$13.6M+70.8% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$59.0K-9.2% YoYEPS (Basic) HistoryBasic earnings per share-$0.76+7.3% YoY